__NUXT_JSONP__("/drugs/Thorium_Th_227_Anetumab_Corixetan", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"2222980-98-3",chebiId:b,chemicalFormula:b,definition:"A radioimmunoconjugate consisting of anetumab, a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein mesothelin, conjugated to the chelating agent corixetan, and labeled with the alpha-emitting radioisotope thorium Th 227, with potential antineoplastic activity. Upon administration of thorium Th 227 anetumab corixetan, the anetumab moiety binds to the tumor-associated antigen (TAA) mesothelin, delivering a cytotoxic dose of alpha radiation to cells expressing mesothelin.",fdaUniiCode:"22OG9ZC9MN",identifier:"C155977",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1511"],synonyms:["227Th Anetumab Corixetan","ANETUMAB CORIXETAN THORIUM TH-227","BAY 2287411","BAY2287411",c,"Thorium Th 227 Monoclonal Antibody BAY2287411","Thorium-227 Labeled Anetumab","Thorium-227 Labeled Antibody-chelator Conjugate BAY2287411"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FThorium_Th_227_Anetumab_Corixetan",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Thorium_Th_227_Anetumab_Corixetan","","Thorium Th 227 Anetumab Corixetan","2021-10-30T13:34:17.003Z")));